Overcoming Bioanalytical Challenges in Anti-Drug Antibody Detection for ADCs

Discover how expert bioanalytical teams are tackling the complexities of antibody-drug conjugate (ADC) development in our on-demand webinar, “Overcoming Bioanalytical Challenges in Anti-Drug Antibody Detection for ADCs.” Join Martin Roberge, PhD, Director of Development & Innovation at HBRI, as he shares a real-world case study and practical strategies to address high rates of pre-existing antibodies, method validation hurdles, and assay sensitivity optimization in ADC clinical trials. Gain actionable insights into adapting ADA assay design to the unique demands of next-generation drug modalities and learn valuable lessons that can inform your own approach to complex biologic drug development. 

Fill the form below to watch the webinar for free.